Further Moestue et al. 26 showed that a 3 day treatment of xenografts representing basal-like breast cancer with MK2206 or the dual PI3K/mTOR inhibitor BEZ235, which decreased pAkt expression significantly increased PCho levels. Here, MTOR is linked to breast carcinoma.